Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.08 USD
Change Today 0.00 / 0.00%
Volume 6.6K
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wei-Wei Zhang M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 39 board members in 2 different organizations across 4 different industries.

See Board Relationships
58--

Background*

Dr. Wei-Wei Zhang, Md, Phd is Founder of GenWay Biotech, Inc. and serves as its President and Chief Executive Officer. Dr. Zhang serves as Chief Executive Officer of Burrill Adventin Capital Management Ltd., and founded in 2011. Dr. Zhang has 21 years of biomedical research experience and 10-years of R&D management experience in gene expression and `antibody development. He founded Introgen Therapeutics Inc., Shenzhen SiBiono, GenStar Therapeutics, Zhuhai Bioinforbody, ...

Read Full Background

Corporate Headquarters*

1330 Avenue of the Americas
New York, New York 10019

United States

Phone: 212-653-0946
Fax: --

Board Members Memberships*

2015-Present
Director and Member of Nominating Committee

Education*

MS 1985
Zhejiang University
Post-Doctoral Training
Baylor College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VKIN:US $0.08 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Parker H. Petit Chairman and Chief Executive Officer
MiMedx Group, Inc.
$914.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIKING INVESTMENTS GROUP INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.